Turtle Creek Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$427K	Buy	809 +91	+13%	+$51K	0.02%	290
2026 Q1	$403K	Sell	718 -306	-30%	-$196K	0.03%	265
2025 Q4	$693K	Buy	1,024 +582	+132%	+$396K	0.05%	192
2025 Q3	$282K	Buy	+442	New	+$268K	0.03%	289
2024 Q1	–	Sell	-257	Closed	-$143K	–	488
2023 Q4	$143K	Buy	+257	New	+$121K	0.04%	164

Other funds holding IDXX

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Turtle Creek Wealth Advisors's IDXX Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, buying an estimated $51K and bringing the position to 809 shares worth $427K. The position accounts for 0.02% of the portfolio, ranked #290.

Turtle Creek Wealth Advisors first reported a position in IDXX in Q4 2023 and has held it in 5 quarters since. The position peaked at $693K in Q4 2025. 572 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Turtle Creek Wealth Advisors held 809 shares of Idexx Laboratories worth $427K as of Q2 2026.
Turtle Creek Wealth Advisors bought 91 Idexx Laboratories shares in Q2 2026, an estimated $51K.
Idexx Laboratories made up 0.02% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #290 holding.
Turtle Creek Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 5 quarters since.
Turtle Creek Wealth Advisors's Idexx Laboratories position peaked at $693K in Q4 2025.
572 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.